MEDAG and triple-A syndrome: MEDAG is a novel adipogenesis gene involved in visceral obesity that is strongly associated with the onset and progression of type 2 diabetes (Yang and Yu, 2021) and can increase the risk of obesity (D'Angelo et al., 2018), which is related to the development and rupture of AAA.